Table of Contents Chapter 1 Human Vaccine Adjuvants Market Overview 1.1 Human Vaccine Adjuvants Definition 1.2 Global Human Vaccine Adjuvants Market Size Status and Outlook (2015-2030) 1.3 Global Human Vaccine Adjuvants Market Size Comparison by Region (2015-2030) 1.4 Global Human Vaccine Adjuvants Market Size Comparison by Type (2015-2030) 1.5 Global Human Vaccine Adjuvants Market Size Comparison by Application (2015-2030) 1.6 Global Human Vaccine Adjuvants Market Size Comparison by Sales Channel (2015-2030) 1.7 Human Vaccine Adjuvants Market Dynamics (COVID-19 Impacts) 1.7.1 Market Drivers/Opportunities 1.7.2 Market Challenges/Risks 1.7.3 Market News (Mergers/Acquisitions/Expansion) 1.7.4 COVID-19 Impacts on Current Market 1.7.5 Post-Strategies of COVID-19 Outbreak Chapter 2 Human Vaccine Adjuvants Market Segment Analysis by Player 2.1 Global Human Vaccine Adjuvants Sales and Market Share by Player (2018-2020) 2.2 Global Human Vaccine Adjuvants Revenue and Market Share by Player (2018-2020) 2.3 Global Human Vaccine Adjuvants Average Price by Player (2018-2020) 2.4 Players Competition Situation & Trends 2.5 Conclusion of Segment by Player Chapter 3 Human Vaccine Adjuvants Market Segment Analysis by Type 3.1 Global Human Vaccine Adjuvants Market by Type 3.1.1 Oral 3.1.2 Subcutaneous 3.1.3 Intramuscular 3.1.4 Others 3.2 Global Human Vaccine Adjuvants Sales and Market Share by Type (2015-2020) 3.3 Global Human Vaccine Adjuvants Revenue and Market Share by Type (2015-2020) 3.4 Global Human Vaccine Adjuvants Average Price by Type (2015-2020) 3.5 Leading Players of Human Vaccine Adjuvants by Type in 2020 3.6 Conclusion of Segment by Type Chapter 4 Human Vaccine Adjuvants Market Segment Analysis by Application 4.1 Global Human Vaccine Adjuvants Market by Application 4.1.1 Research Applications 4.1.2 Commercial Applications 4.2 Global Human Vaccine Adjuvants Revenue and Market Share by Application (2015-2020) 4.3 Leading Consumers of Human Vaccine Adjuvants by Application in 2020 4.4 Conclusion of Segment by Application Chapter 5 Human Vaccine Adjuvants Market Segment Analysis by Sales Channel 5.1 Global Human Vaccine Adjuvants Market by Sales Channel 5.1.1 Direct Channel 5.1.2 Distribution Channel 5.2 Global Human Vaccine Adjuvants Revenue and Market Share by Sales Channel (2015-2020) 5.3 Leading Distributors/Dealers of Human Vaccine Adjuvants by Sales Channel in 2020 5.4 Conclusion of Segment by Sales Channel Chapter 6 Human Vaccine Adjuvants Market Segment Analysis by Region 6.1 Global Human Vaccine Adjuvants Market Size and CAGR by Region (2015-2030) 6.2 Global Human Vaccine Adjuvants Sales and Market Share by Region (2015-2020) 6.3 Global Human Vaccine Adjuvants Revenue and Market Share by Region (2015-2020) 6.4 North America 6.4.1 North America Market by Country 6.4.2 North America Human Vaccine Adjuvants Market Share by Type 6.4.3 North America Human Vaccine Adjuvants Market Share by Application 6.4.4 United States 6.4.5 Canada 6.4.6 Mexico 6.5 Europe 6.5.1 Europe Market by Country 6.5.2 Europe Human Vaccine Adjuvants Market Share by Type 6.5.3 Europe Human Vaccine Adjuvants Market Share by Application 6.5.4 Germany 6.5.5 UK 6.5.6 France 6.5.7 Italy 6.5.8 Russia 6.5.9 Spain 6.6 Asia-Pacific 6.6.1 Asia-Pacific Market by Country 6.6.2 Asia-Pacific Human Vaccine Adjuvants Market Share by Type 6.6.3 Asia-Pacific Human Vaccine Adjuvants Market Share by Application 6.6.4 China 6.6.5 Japan 6.6.6 Korea 6.6.7 India 6.6.8 Southeast Asia 6.6.9 Australia 6.7 South America 6.7.1 South America Market by Country 6.7.2 South America Human Vaccine Adjuvants Market Share by Type 6.7.3 South America Human Vaccine Adjuvants Market Share by Application 6.7.4 Brazil 6.7.5 Argentina 6.7.6 Colombia 6.8 Middle East & Africa 6.8.1 Middle East & Africa Market by Country 6.8.2 Middle East & Africa Human Vaccine Adjuvants Market Share by Type 6.8.3 Middle East & Africa Human Vaccine Adjuvants Market Share by Application 6.8.4 UAE 6.8.5 Saudi Arabia 6.8.6 South Africa 6.9 Conclusion of Segment by Region Chapter 7 Profile of Leading Human Vaccine Adjuvants Players 7.1 GSK 7.1.1 Company Snapshot 7.1.2 Product/Service Offered 7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share) 7.1.4 COVID-19 Impact on GSK 7.2 CSL Limited 7.3 Brenntag Biosector 7.4 SEPPIC 7.5 SPI Pharma 7.6 Novavax 7.7 Avanti Polar Lipids 7.8 Aphios Chapter 8 Upstream and Downstream Analysis of Human Vaccine Adjuvants 8.1 Industrial Chain of Human Vaccine Adjuvants 8.2 Upstream of Human Vaccine Adjuvants 8.2.1 Raw Materials 8.2.2 Labor Cost 8.2.3 Manufacturing Expenses 8.2.4 Manufacturing Cost Structure 8.2.5 Manufacturing Process 8.3 Downstream of Human Vaccine Adjuvants 8.3.1 Leading Distributors/Dealers of Human Vaccine Adjuvants 8.3.2 Leading Consumers of Human Vaccine Adjuvants Chapter 9 Development Trend of Human Vaccine Adjuvants (2021-2030) 9.1 Global Human Vaccine Adjuvants Market Size (Sales and Revenue) Forecast (2021-2030) 9.2 Global Human Vaccine Adjuvants Market Size and CAGR Forecast by Region (2021-2030) 9.3 Global Human Vaccine Adjuvants Market Size and CAGR Forecast by Type (2021-2030) 9.4 Global Human Vaccine Adjuvants Market Size and CAGR Forecast by Application (2021-2030) 9.5 Global Human Vaccine Adjuvants Market Size and CAGR Forecast by Sales Channel (2021-2030) Chapter 10 Appendix 10.1 Research Methodology 10.2 Data Sources 10.3 Disclaimer 10.4 Analysts Certification

List of Tables and Figures Figure Human Vaccine Adjuvants Example Figure Global Human Vaccine Adjuvants Revenue (Million $) Status and Outlook (2015-2030) Figure Global Human Vaccine Adjuvants Revenue (Million $) Comparison by Region (2015-2030) Figure Global Human Vaccine Adjuvants Revenue (Million $) Comparison by Type (2015-2030) Figure Global Human Vaccine Adjuvants Revenue (Million $) Comparison by Application (2015-2030) Figure Global Human Vaccine Adjuvants Revenue (Million $) Comparison by Sales Channel (2015-2030) Table Global Human Vaccine Adjuvants Sales by Player (2018-2020) Table Global Human Vaccine Adjuvants Sales Market Share by Player (2018-2020) Figure Global Human Vaccine Adjuvants Sales Market Share by Player in 2020 Table Global Human Vaccine Adjuvants Revenue (Million $) by Player (2018-2020) Table Global Human Vaccine Adjuvants Revenue Market Share by Player (2018-2020) Figure Global Human Vaccine Adjuvants Revenue Market Share by Player in 2020 Table Global Human Vaccine Adjuvants Average Price by Player (2018-2020) Figure Global Human Vaccine Adjuvants Average Price by Player in 2020 Figure Global Human Vaccine Adjuvants Players Competition Situation – Top 5 Players’ Revenue Market Share in 2018 Figure Global Human Vaccine Adjuvants Players Competition Trends – Top 5 Players’ Revenue Market Share in 2020 Figure Example of Oral Figure Global Oral Revenue (Million $) and Growth Rate (2015-2020) Figure Example of Subcutaneous Figure Global Subcutaneous Revenue (Million $) and Growth Rate (2015-2020) Figure Example of Intramuscular Figure Global Intramuscular Revenue (Million $) and Growth Rate (2015-2020) Figure Example of Others Figure Global Others Revenue (Million $) and Growth Rate (2015-2020) Table Global Human Vaccine Adjuvants Sales by Type (2015-2020) Table Global Human Vaccine Adjuvants Sales Market Share by Type (2015-2020) Figure Global Human Vaccine Adjuvants Sales Market Share by Type in 2020 Table Global Human Vaccine Adjuvants Revenue (Million $) by Type (2015-2020) Table Global Human Vaccine Adjuvants Revenue Market Share by Type (2015-2020) Figure Global Human Vaccine Adjuvants Revenue Market Share by Type in 2020 Table Global Human Vaccine Adjuvants Average Price by Type (2015-2020) Figure Global Human Vaccine Adjuvants Average Price by Type in 2020 Table Leading Players of Human Vaccine Adjuvants by Type in 2020 Figure Example of Research Applications Figure Global Human Vaccine Adjuvants for Research Applications Revenue (Million $) and Growth Rate (2015-2020) Figure Example of Commercial Applications Figure Global Human Vaccine Adjuvants for Commercial Applications Revenue (Million $) and Growth Rate (2015-2020) Table Global Human Vaccine Adjuvants Sales by Application (2015-2020) Table Global Human Vaccine Adjuvants Sales Market Share by Application (2015-2020) Figure Global Human Vaccine Adjuvants Sales Market Share by Application in 2020 Table Leading Consumers of Human Vaccine Adjuvants by Application in 2020 Figure Example of Direct Channel Figure Global Human Vaccine Adjuvants for Direct Channel Revenue (Million $) and Growth Rate (2015-2020) Figure Example of Distribution Channel Figure Global Human Vaccine Adjuvants for Distribution Channel Revenue (Million $) and Growth Rate (2015-2020) Table Global Human Vaccine Adjuvants Revenue by Sales Channel (2015-2020) Table Global Human Vaccine Adjuvants Revenue Market Share by Sales Channel (2015-2020) Figure Global Human Vaccine Adjuvants Revenue Market Share by Sales Channel in 2020 Table Leading Distributors/Dealers of Human Vaccine Adjuvants by Sales Channel in 2020 Table Global Human Vaccine Adjuvants Market Size and CAGR by Region (2015-2030) Table Global Human Vaccine Adjuvants Sales by Region (2015-2020) Table Global Human Vaccine Adjuvants Sales Market Share by Region (2015-2020) Figure Global Human Vaccine Adjuvants Sales Market Share by Region in 2020 Table Global Human Vaccine Adjuvants Revenue (Million $) by Region (2015-2020) Table Global Human Vaccine Adjuvants Revenue Market Share by Region (2015-2020) Figure Global Human Vaccine Adjuvants Revenue Market Share by Region in 2020 Table North America Human Vaccine Adjuvants Sales by Country (2015-2020) Figure North America Human Vaccine Adjuvants Sales Market Share by Country (2015-2020) Table North America Human Vaccine Adjuvants Revenue by Country (2015-2020) Figure North America Human Vaccine Adjuvants Revenue Market Share by Country (2015-2020) Figure North America Human Vaccine Adjuvants Market Share by Type in 2020 Figure North America Human Vaccine Adjuvants Market Share by Application in 2020 Figure United States Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) Figure United States Human Vaccine Adjuvants Revenue (Million $) and Growth Rate (2015-2020) Figure Canada Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) Figure Canada Human Vaccine Adjuvants Revenue (Million $) and Growth Rate (2015-2020) Figure Mexico Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) Figure Mexico Human Vaccine Adjuvants Revenue (Million $) and Growth Rate (2015-2020) Table Europe Human Vaccine Adjuvants Sales by Country (2015-2020) Figure Europe Human Vaccine Adjuvants Sales Market Share by Country (2015-2020) Table Europe Human Vaccine Adjuvants Revenue by Country (2015-2020) Figure Europe Human Vaccine Adjuvants Revenue Market Share by Country (2015-2020) Figure Europe Human Vaccine Adjuvants Market Share by Type in 2020 Figure Europe Human Vaccine Adjuvants Market Share by Application in 2020 Figure Germany Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) Figure Germany Human Vaccine Adjuvants Revenue (Million $) and Growth Rate (2015-2020) Figure UK Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) Figure UK Human Vaccine Adjuvants Revenue (Million $) and Growth Rate (2015-2020) Figure France Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) Figure France Human Vaccine Adjuvants Revenue (Million $) and Growth Rate (2015-2020) Figure Italy Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) Figure Italy Human Vaccine Adjuvants Revenue (Million $) and Growth Rate (2015-2020) Figure Russia Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) Figure Russia Human Vaccine Adjuvants Revenue (Million $) and Growth Rate (2015-2020) Figure Spain Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) Figure Spain Human Vaccine Adjuvants Revenue (Million $) and Growth Rate (2015-2020) Table Asia-Pacific Human Vaccine Adjuvants Sales by Country (2015-2020) Figure Asia-Pacific Human Vaccine Adjuvants Sales Market Share by Country (2015-2020) Table Asia-Pacific Human Vaccine Adjuvants Revenue by Country (2015-2020) Figure Asia-Pacific Human Vaccine Adjuvants Revenue Market Share by Country (2015-2020) Figure Asia-Pacific Human Vaccine Adjuvants Market Share by Type in 2020 Figure Asia-Pacific Human Vaccine Adjuvants Market Share by Application in 2020 Figure China Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) Figure China Human Vaccine Adjuvants Revenue (Million $) and Growth Rate (2015-2020) Figure Japan Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) Figure Japan Human Vaccine Adjuvants Revenue (Million $) and Growth Rate (2015-2020) Figure Korea Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) Figure Korea Human Vaccine Adjuvants Revenue (Million $) and Growth Rate (2015-2020) Figure India Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) Figure India Human Vaccine Adjuvants Revenue (Million $) and Growth Rate (2015-2020) Figure Southeast Asia Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) Figure Southeast Asia Human Vaccine Adjuvants Revenue (Million $) and Growth Rate (2015-2020) Figure Australia Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) Figure Australia Human Vaccine Adjuvants Revenue (Million $) and Growth Rate (2015-2020) Table South America Human Vaccine Adjuvants Sales by Country (2015-2020) Figure South America Human Vaccine Adjuvants Sales Market Share by Country (2015-2020) Table South America Human Vaccine Adjuvants Revenue by Country (2015-2020) Figure South America Human Vaccine Adjuvants Revenue Market Share by Country (2015-2020) Figure South America Human Vaccine Adjuvants Market Share by Type in 2020 Figure South America Human Vaccine Adjuvants Market Share by Application in 2020 Figure Brazil Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) Figure Brazil Human Vaccine Adjuvants Revenue (Million $) and Growth Rate (2015-2020) Figure Argentina Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) Figure Argentina Human Vaccine Adjuvants Revenue (Million $) and Growth Rate (2015-2020) Figure Colombia Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) Figure Colombia Human Vaccine Adjuvants Revenue (Million $) and Growth Rate (2015-2020) Table Middle East & Africa Human Vaccine Adjuvants Sales by Country (2015-2020) Figure Middle East & Africa Human Vaccine Adjuvants Sales Market Share by Country (2015-2020) Table Middle East & Africa Human Vaccine Adjuvants Revenue by Country (2015-2020) Figure Middle East & Africa Human Vaccine Adjuvants Revenue Market Share by Country (2015-2020) Figure Middle East & Africa Human Vaccine Adjuvants Market Share by Type in 2020 Figure Middle East & Africa Human Vaccine Adjuvants Market Share by Application in 2020 Figure UAE Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) Figure UAE Human Vaccine Adjuvants Revenue (Million $) and Growth Rate (2015-2020) Figure Saudi Arabia Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) Figure Saudi Arabia Human Vaccine Adjuvants Revenue (Million $) and Growth Rate (2015-2020) Figure South Africa Human Vaccine Adjuvants Sales and Growth Rate (2015-2020) Figure South Africa Human Vaccine Adjuvants Revenue (Million $) and Growth Rate (2015-2020) Table Company Snapshot of GSK Table Human Vaccine Adjuvants Introduction of GSK Table Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share of GSK (2018-2020) Table Industrial Chain of Human Vaccine Adjuvants Table Manufacturing Cost Structure of Human Vaccine Adjuvants Table General Manufacturing Process of Human Vaccine Adjuvants Table Leading Distributors/Dealers of Human Vaccine Adjuvants Table Leading Consumers of Human Vaccine Adjuvants Figure Global Human Vaccine Adjuvants Sales and Growth Rate Forecast (2021-2030) Figure Global Human Vaccine Adjuvants Revenue and Growth Rate Forecast (2021-2030) Table Global Human Vaccine Adjuvants Market Size and CAGR Forecast by Region (2021-2030) Table Global Human Vaccine Adjuvants Market Size and CAGR Forecast by Type (2021-2030) Table Global Human Vaccine Adjuvants Market Size and CAGR Forecast by Application (2021-2030) Table Global Human Vaccine Adjuvants Market Size and CAGR Forecast by Sales Channel (2021-2030)

Leading players of Human Vaccine Adjuvants including: GSK CSL Limited Brenntag Biosector SEPPIC SPI Pharma Novavax Avanti Polar Lipids Aphios